4//SEC Filing
PHARMACIA CORP /DE/ 4
Accession 0000950117-03-001516
CIK 0000067686operating
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:26 PM ET
Size
20.4 KB
Accession
0000950117-03-001516
Insider Transaction Report
Form 4
No transactions or holdings reported in this filing.
Footnotes (5)
- [1]Each share of Pharmacia Common Stock (PHA) held by the reporting person was exchanged for 1.4 shares of Pfizer Common Stock (PFE), pursuant to the Pfizer/Pharmacia merger agreement adopted by the Pfizer and Pharmacia shareholders on December 6 & 9, 2002, respectively.
- [2]Option is currently exercisable.
- [3]Target awards provided under the Founders Performance Contingent Shares Program vest at the greater of the target award or the percentage of the target award payable based on the period-to-date performance calculated as of the date of the change in control. The award increases to 125% of the participant's target award if the participant is employed by the company or an affiliate two years after the change in control, or is involuntarily terminated other than for cause within two years after change in control and, is such amount is greater than the calculation above.
- [4]At the end of each calendar year 2002, 2003 and 2004, 1/3 of the units will be eligible for allocation based on Company performance for that year.
- [5]Distribution under the plan commences the calendar year following retirement, termination, death or disability, based on the provisions of the Savings+Plus deferred compensation plan. /s/ Don W. Schmitz April 16, 2003 -------------------------------- ----------------- **
Documents
Issuer
PHARMACIA CORP /DE/
CIK 0000067686
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000067686
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:26 PM ET
- Size
- 20.4 KB